Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.
about
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and PrognosisIn situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding.Continued rapid growth in (68) Ga applications: update 2013 to June 2014.Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging.[(18)F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma.PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis.Mismatch between perfusion and metabolism in locally advanced breast cancer.Preparation and evaluation of a 68Ga-labeled RGD-containing octapeptide for noninvasive imaging of angiogenesis: biodistribution in non-human primate.Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies.
P2860
Q26771417-C4FA450C-C92F-4F5A-A97A-8E3158D3816CQ33685937-A162C568-0428-45E8-A01E-D812418C5026Q33687901-371271A1-D7CE-4D41-B383-7620B160119FQ36228314-A795500F-918B-459A-B1FB-8342CFFEE7ECQ36510864-05670084-4DD3-48AE-88E7-F33D9A5A0EC3Q38358666-47D2BE28-49D7-4F6D-9888-99A17EDC047FQ38936273-A52B5C8E-66C0-4A3A-B5D4-46B5F88929F4Q50100711-76740435-87C8-4D5D-8335-E58AF88F38B6Q50553926-2EE13F8B-2AE1-494B-AE3A-E9C39B53F47BQ51135004-3451CCAA-9C80-4A12-A3C1-6703965A9950Q54257268-1BAFDCF3-714F-4487-818F-6B7E3A5F3133Q54948216-17A57977-7213-4B0F-8914-D8C765A04A3FQ55070638-F066B311-0E45-4868-8EF4-16CDCEF4B841Q55098453-746992FE-9FCA-4C6C-B9A3-730A5E66992CQ55405589-C5D3345A-A6BB-47B8-91BF-865F10FAC26B
P2860
Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Correlation of breast cancer s ...... RGD PET/CT and ¹⁸F-FDG PET/CT.
@en
type
label
Correlation of breast cancer s ...... RGD PET/CT and ¹⁸F-FDG PET/CT.
@en
prefLabel
Correlation of breast cancer s ...... RGD PET/CT and ¹⁸F-FDG PET/CT.
@en
P2093
P2860
P1476
Correlation of breast cancer s ...... RGD PET/CT and ¹⁸F-FDG PET/CT.
@en
P2093
Dong Soo Lee
Hai-Jeon Yoon
Jae Min Jeong
June-Key Chung
Kyeong Cheon Jung
Nariya Cho
Seock-Ah Im
Sunjoo Jeong
Woo Kyung Moon
P2860
P2888
P304
P356
10.1007/S00259-014-2744-4
P577
2014-03-21T00:00:00Z